- Filed
- Sep 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Sep 8, 2025 | 29.83M sh |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $2.1M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $1.75M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $2.1M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $1.75M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $8.06K |
| Current Assets | Q2 2025 · Sep 30, 2024 | $21.68K |
| Total Assets | Q2 2025 · Mar 31, 2025 | $21.04K |
| Total Assets | Q2 2025 · Sep 30, 2024 | $35.58K |
| Eps Basic | Q2 2025 · Mar 31, 2025 | −$0.01 |
| Eps Basic | Q2 2025 · Mar 31, 2025 | −$0.23 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.04 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.11 |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 19.67M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 19.6M sh |
| Operating Cash Flow restated | Q2 2025 · Mar 31, 2024 | −$870K |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | −$1.1M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | −$1.19M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | −$1.7M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.04 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.11 |
| Rd Expense restated | Q2 2025 · Mar 31, 2024 | $6.08K |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $33.11K |
| Net Income | Q2 2025 · Mar 31, 2024 | −$772.06K |
| Net Income | Q2 2025 · Mar 31, 2024 | −$2.12M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$1.35M |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$747.4K |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$2.05M |